Impact of antiplatelet therapy on hemostatic plug formation in the setting of thrombocytopenia
Background: Antiplatelet therapy (APT), mainly aspirin and P2Y12 receptor inhibitors, reduces the incidence of recurrent arterial thrombosis but also increases bleeding risk. Therefore, management of APT in patients with thrombocytopenia, itself an independent risk factor for bleeding, is a clinical...
Saved in:
Main Authors: | Robert H. Lee, Abigail Ballard-Kordeliski, Summer R. Jones, Wolfgang Bergmeier |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2475037924003674 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dual Antiplatelet Therapy Regimens and Duration for Intracranial Stenting Procedures: Literature Review
by: Milda Paliulytė, et al.
Published: (2023-11-01) -
Comparative efficacy of clopidogrel-aspirin combination therapy versus aspirin monotherapy in preventing recurrent events in transient ischemic attack and minor stroke: a systematic review and meta-analysis
by: Ahmad Mujtaba Bhutto, et al.
Published: (2025-02-01) -
Early Neurologic Deterioration and Efficacy of Dual Antiplatelet in Anterior Versus Posterior Circulation Stroke
by: Yu Cui, et al.
Published: (2025-02-01) -
The effect of sarpogrelate compared to aspirin in high- or very-high-risk diabetes for primary prevention
by: Soo Hyun Kang, et al.
Published: (2025-01-01) -
Dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) in patients with chronic coronary artery disease (CAD) - current state of knowledge and perspective for further research
by: Hubert Bochenek, et al.
Published: (2025-02-01)